Investing.com -- Q32 Bio Inc (NASDAQ:QTTB) stock surged 94% in premarket trading Monday after the clinical-stage biotechnology company announced the sale of its Phase 2 complement inhibitor, ADX-097, ...

Q32 Bio Inc (NASDAQ:QTTB) saw its stock skyrocket 94% in premarket trading on Monday after revealing that it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics (NASDAQ:AKBA).

AVCA North Region Freshman of the Year • AVCA All-North Region • First Team All-Big Ten • Big Ten All-Freshman Team • Big Ten/Big 12 Challenge All-Tournament Team selection and Best Defender Award ...

Artemis 2 will be the first mission to carry humans to the moon's vicinity since 1972. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Artemis 2 ...

Helena’s Thomas Booth served two tours in Vietnam, in 1965-66 and 1969-70, with the 101st Airborne.

New England Patriots Not unlike his playing days, Year 2 Tom Brady is putting it together in the broadcast booth Brady still does have lingering flaws, but he has figured out an essential part of the ...